Levin, Michael
Funding for this research was provided by:
John Templeton Foundation (62212)
Astonishing Labs
Article History
Received: 28 November 2022
Revised: 12 April 2023
Accepted: 24 April 2023
First Online: 19 May 2023
Declarations
:
: M.L. declares that he is a co-founder of a company, Morphoceuticals, which works in the space of bioelectric signals for regenerative medicine.
: Not applicable.